An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer
Prostate Cancer · 2011
DOI: 10.1155/2011/419174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prostate Cancer, 2011. Verfasst von Kristene Myklak und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, CO 80045, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Quality of life has become increasingly more important for men diagnosed with prostate cancer. In light of this and the recognized risks of androgen deprivation therapy (ADT), the guidelines and use of ADT have changed significantly over the last few years. This paper reviews the current recommendations and the future perspectives regarding ADT. The benefits of ADT are evident neoadjuvantly and adjuvantly in patients treated with external beam radiation therapy for intermediate- and high-risk disease, in patients who have undergone prostatectomy with lymph node involvement, in high-risk patients after definitive therapy, and in patients who have developed progression or metastasis. Finally, this paper reviews the risks and benefits of each of these scenarios and the risks of androgen deprivation in general, and it delineates the areas where ADT was previously recommended, but where evidence is lacking for its additional benefit.
Autor:innen und Institutionen
- Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, CO 80045, USA.
Zitieren
APA
Myklak, K., & Wilson, S. (2011). An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer. Prostate Cancer. https://doi.org/10.1155/2011/419174
Vancouver
Myklak K, Wilson S. An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer. Prostate Cancer. 2011. doi:10.1155/2011/419174
BibTeX
@article{Myklak2011,
author = {Myklak, Kristene and Wilson, Shandra},
title = {An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer},
journal = {Prostate Cancer},
year = {2011},
doi = {10.1155/2011/419174}
}
EUVIMED